Randomized Trial of the Immunogenicity and Safety of the Hepatitis B Vaccine Given in an Accelerated Schedule Coadministered with the Human Papillomavirus Type 16/18 AS04-Adjuvanted Cervical Cancer Vaccine

The human papillomavirus type 16/18 (HPV-16/18) AS04-adjuvanted cervical cancer vaccine is licensed for females aged 10 years and above and is therefore likely to be coadministered with other licensed vaccines, such as hepatitis B. In this randomized, open-label study, we compared the immunogenicity...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Leroux-Roels, Geert, Haelterman, Edwige, Maes, Cathy, Levy, Jack, De Boever, Fien, Licini, Laurent, David, Marie-Pierre, Dobbelaere, Kurt, Descamps, Dominique
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2011
Témata:
Vaccine Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3165228/
https://ncbi.nlm.nih.gov/pubmed/21734063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00539-10
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky